Legacy Capital Partners, Inc. / ABT
Legacy Capital Partners, Inc.’s Abbott Laboratories Position
Does Legacy Capital Partners, Inc. own Abbott Laboratories (ABT)? Yes — 59.8K shares worth $7M (+2.33% of its 13F portfolio) as of Q1 2022, down from 60.0K shares the prior filed quarter.
Position Value
$7M
Q1 2022
Shares
59.8K
% of Portfolio
+2.33%
Quarters Held
14
currently held
Position History ABT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2022 | 59.8K | $7M | +2.33% |
| Q4 2021 | 60.0K | $8M | +2.73% |
| Q3 2021 | 60.2K | $7M | +2.58% |
| Q2 2021 | 60.8K | $7M | +2.52% |
| Q1 2021 | 61.2K | $7M | +2.77% |
| Q4 2020 | 62.2K | $7M | +2.67% |
| Q3 2020 | 67.4K | $7M | +2.97% |
| Q2 2020 | 64.5K | $6M | +2.53% |
| Q1 2020 | 67.0K | $5M | +2.62% |
| Q4 2019 | 63.8K | $6M | +2.23% |
| Q3 2019 | 63.6K | $5M | +2.33% |
| Q2 2019 | 64.0K | $5M | +2.39% |
| Q1 2019 | 64.6K | $5M | +2.41% |
| Q4 2018 | 66.9K | $5M | +2.56% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Legacy Capital Partners, Inc.’s full portfolio or all institutional holders of ABT.